Alnylam Pharmaceuticals, Inc. v. Pfizer Inc. et al

  1. August 20, 2024

    Vax Patent Battles Heat Up As Attention On Pandemic Wanes

    It's been over four years since clinical trials began for COVID-19 vaccines, and while the shots have helped the pandemic recede, the lucrative technology has spurred numerous patent suits, many of which are still in the early stages. Here's a look at some of the key cases in the U.S.

  2. May 30, 2023

    Alnylam Widens Vaccine IP Litigation Against Pfizer, Moderna

    Shortly after obtaining additional patents on vaccine delivery technology from the U.S. Patent and Trademark Office, pharmaceutical company Alnylam has expanded its infringement litigation against Pfizer and Moderna over their COVID-19 vaccines.